Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01460394 · ClinicalTrials.gov registry record
Normative Data of Brain Network Activation in Adolescents and Young Adults
A clinical trial, sponsored by ElMindA.
- Completed
- Registry status
- 64
- Enrollment target
NCT01460394: Completed study, sponsored by ElMindA.
NCT01460394 is a clinical trial that has completed, run by ElMindA. The registered enrollment target is 64 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01460394 has completed, sponsored by ElMindA.
- COMPLETED
- Registry status
- 64 participants
- Enrollment target
Study Summary
Establish normative data of ElMindA's Brain Network Activation (BNA) using evoked response in two age groups: adolescents and young adults.
Primary Outcome
The study outcome measure are functional networks of brain activity of healthy adolescents (age 15-18 years) and young adults (19-24 years) established based on an analysis of EEG data recorded while study subjects perform ERP tasks
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 64 participants |
| Start Date | 2011-10 |
| Est. Completion | 2012-04 |
What the finished NCT01460394 record still lists
NCT01460394 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 64 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT01460394 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01460394 about?
NCT01460394 is a clinical study titled "Normative Data of Brain Network Activation in Adolescents and Young Adults". Establish normative data of ElMindA's Brain Network Activation (BNA) using evoked response in two age groups: adolescents and young adults.
What is the current status of trial NCT01460394?
This trial is currently completed. The enrollment target is 64 participants. The study started on 2011-10. Estimated completion is 2012-04.
Who is sponsoring clinical trial NCT01460394?
This trial is sponsored by ElMindA, which has 12 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01853631 · 64 participants · Phase 1
Activated T-Cells Expressing 2nd or 3rd Generation CD19-Specific CAR, Advanced B-Cell NHL, ALL, and CLL (SAGAN)
- NCT03739502 · 64 participants · Phase 2
A Randomized Phase II Study of Hyperbaric Oxygen in Improving Engraftment in Umbilical Cord Blood Stem Cell Transplant
- NCT03739814 · 64 participants · Phase 2
Inotuzumab Ozogamicin and Blinatumomab With or Without Ponatinib in Treating Patients With Newly Diagnosed, Recurrent, or Refractory CD22-Positive B-Lineage Acute Lymphoblastic Leukemia
- NCT03866408 · 64 participants · Early Phase 1
Insulin Regulation of Lipolysis and Lipolysis Proteins
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia